Diffusion-weighted magnetic resonance imaging and neurobiochemical markers after aortic valve replacement: implications for future neuroprotective trials?
D000368:Aged; D001021:Aortic Valve / Q000601:surgery*; D015415:Biomarkers / Q000097:blood; D002986:Clinical Trials as Topic; D038524:Diffusion Magnetic Resonance Imaging; D005260:Female; D019918:Heart Valve Prosthesis Implantation; D006801:Humans; D020766:Intracranial Embolism / Q000175:diagnosis*; D008297:Male; D008875:Middle Aged; D009414:Nerve Growth Factors / Q000097:blood; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010751:Phosphopyruvate Hydratase / Q000097:blood; D064568:S100 Calcium Binding Protein beta Subunit; D009418:S100 Proteins / Q000097:blood; D020521:Stroke / Q000517:prevention & control
D015415:Biomarkers; D009414:Nerve Growth Factors; D018696:Neuroprotective Agents; D064568:S100 Calcium Binding Protein beta Subunit; D009418:S100 Proteins; D010751:Phosphopyruvate Hydratase